Livzon Pharmaceutical Group Inc. (SHE:000513)
China · Delayed Price · Currency is CNY 26.41
-0.35 (-1.31%)
Aug 31, 2026, 3:04 PM CST
SHE:000513 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 7,550 | 9,305 | 10,827 | 11,326 | 10,411 | 9,146 |
Short-Term Investments | 371.42 | 270.56 | - | - | - | - |
Trading Asset Securities | 383.38 | 1,345 | 89.36 | 81.79 | 108.09 | 182.77 |
Cash & Short-Term Investments | 8,305 | 10,921 | 10,917 | 11,408 | 10,519 | 9,329 |
Cash Growth | -23.28% | 0.04% | -4.30% | 8.44% | 12.76% | -6.52% |
Accounts Receivable | 2,663 | 3,386 | 3,249 | 3,575 | 4,039 | 3,294 |
Other Receivables | 90.07 | 90.78 | 59.28 | 51.91 | 31.32 | 64.37 |
Receivables | 2,753 | 3,477 | 3,308 | 3,627 | 4,071 | 3,358 |
Inventory | 1,798 | 1,561 | 1,998 | 2,061 | 2,045 | 1,663 |
Other Current Assets | 256.99 | 159.53 | 197.44 | 171.11 | 352 | 322.42 |
Total Current Assets | 13,113 | 16,118 | 16,420 | 17,266 | 16,987 | 14,673 |
Property, Plant & Equipment | 4,629 | 4,322 | 4,537 | 4,566 | 4,592 | 4,239 |
Long-Term Investments | 3,123 | 1,916 | 2,085 | 1,670 | 1,738 | 1,695 |
Goodwill | 1,095 | 124.91 | 124.91 | 124.91 | 103.04 | 103.04 |
Other Intangible Assets | 461.86 | 468.85 | 403.68 | 426.28 | 557.44 | 260.28 |
Long-Term Deferred Tax Assets | 480.39 | 427.72 | 356.35 | 301.92 | 283.89 | 252.69 |
Long-Term Deferred Charges | 553.73 | 524.74 | 396.25 | 468.62 | 416.74 | 704.41 |
Other Long-Term Assets | 136.45 | 84.09 | 132.55 | 221.17 | 189.66 | 444.62 |
Total Assets | 23,591 | 23,985 | 24,456 | 25,045 | 24,868 | 22,372 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Accounts Payable | 1,334 | 1,318 | 1,584 | 1,658 | 1,862 | 1,817 |
Accrued Expenses | 2,952 | 3,241 | 3,109 | 3,295 | 3,249 | 2,656 |
Short-Term Debt | 3,396 | 2,120 | 2,455 | 1,860 | 1,622 | 2,043 |
Current Portion of Long-Term Debt | - | 157.89 | 36.21 | 647.47 | - | - |
Current Portion of Leases | 15.91 | 15.33 | 12.53 | 12.2 | 10.44 | 9.28 |
Current Income Taxes Payable | 86.32 | 82.43 | 112.88 | 181.58 | 92.57 | 97.45 |
Current Unearned Revenue | 74.21 | 104.38 | 124.63 | 138 | 226.19 | 167.8 |
Other Current Liabilities | 603.54 | 180.71 | 191.27 | 294.49 | 334.42 | 134.34 |
Total Current Liabilities | 8,462 | 7,220 | 7,625 | 8,087 | 7,397 | 6,925 |
Long-Term Debt | 25.9 | 749.36 | 1,466 | 1,613 | 1,974 | 636.78 |
Long-Term Leases | 18.48 | 17.32 | 13.1 | 9.03 | 11.61 | 5.27 |
Long-Term Unearned Revenue | 233.72 | 242.16 | 238.42 | 269.37 | 273.21 | 258.88 |
Long-Term Deferred Tax Liabilities | 248.35 | 210.28 | 207.39 | 209.81 | 191.96 | 156.89 |
Other Long-Term Liabilities | 1.9 | -0.5 | - | 90 | 84 | 78 |
Total Liabilities | 8,994 | 8,438 | 9,550 | 10,278 | 9,932 | 8,061 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Common Stock | 887.91 | 887.91 | 911.35 | 923.94 | 935.55 | 937.87 |
Additional Paid-In Capital | 386.9 | - | 257.85 | 1,322 | 1,422 | 1,629 |
Retained Earnings | 12,401 | 12,738 | 12,506 | 11,653 | 11,182 | 10,461 |
Treasury Stock | - | - | -196.62 | - | -55.94 | -71.21 |
Comprehensive Income & Other | -309.67 | 262.25 | 383.57 | 143.07 | 391.64 | 46.55 |
Total Common Equity | 13,366 | 13,888 | 13,862 | 14,042 | 13,876 | 13,004 |
Minority Interest | 1,232 | 1,659 | 1,043 | 724.21 | 1,060 | 1,307 |
Shareholders' Equity | 14,598 | 15,547 | 14,906 | 14,767 | 14,936 | 14,311 |
Total Liabilities & Equity | 23,591 | 23,985 | 24,456 | 25,045 | 24,868 | 22,372 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Total Debt | 3,456 | 3,060 | 3,983 | 4,141 | 3,619 | 2,694 |
Net Cash (Debt) | 4,849 | 7,861 | 6,934 | 7,266 | 6,901 | 6,635 |
Net Cash Growth | -32.70% | 13.37% | -4.57% | 5.29% | 4.01% | -17.58% |
Net Cash Per Share | 5.45 | 8.80 | 7.53 | 7.81 | 7.37 | 7.09 |
Filing Date Shares Outstanding | 887.91 | 887.91 | 908.91 | 923.94 | 932.23 | 929.97 |
Total Common Shares Outstanding | 887.91 | 887.91 | 908.91 | 923.94 | 932.23 | 929.97 |
Working Capital | 4,651 | 8,898 | 8,795 | 9,179 | 9,591 | 7,748 |
Book Value Per Share | 15.05 | 15.64 | 15.25 | 15.20 | 14.88 | 13.98 |
Tangible Book Value | 11,809 | 13,295 | 13,334 | 13,491 | 13,216 | 12,640 |
Tangible Book Value Per Share | 13.30 | 14.97 | 14.67 | 14.60 | 14.18 | 13.59 |
Buildings | 4,090 | - | - | 3,745 | - | 3,123 |
Machinery | 5,222 | 8,986 | 8,729 | 4,551 | 7,577 | 3,764 |
Construction In Progress | 289.49 | 234.18 | 257.37 | 289.31 | 602.44 | 554.58 |